<code id='B0F5265D0A'></code><style id='B0F5265D0A'></style>
    • <acronym id='B0F5265D0A'></acronym>
      <center id='B0F5265D0A'><center id='B0F5265D0A'><tfoot id='B0F5265D0A'></tfoot></center><abbr id='B0F5265D0A'><dir id='B0F5265D0A'><tfoot id='B0F5265D0A'></tfoot><noframes id='B0F5265D0A'>

    • <optgroup id='B0F5265D0A'><strike id='B0F5265D0A'><sup id='B0F5265D0A'></sup></strike><code id='B0F5265D0A'></code></optgroup>
        1. <b id='B0F5265D0A'><label id='B0F5265D0A'><select id='B0F5265D0A'><dt id='B0F5265D0A'><span id='B0F5265D0A'></span></dt></select></label></b><u id='B0F5265D0A'></u>
          <i id='B0F5265D0A'><strike id='B0F5265D0A'><tt id='B0F5265D0A'><pre id='B0F5265D0A'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:8
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          The new HIV moral panic
          The new HIV moral panic

          Gilead'sPrEPpillTruvadaJustinSullivan/GettyImagesInMay,justbeforePrideMonth,theCentersforDiseaseCont

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          International team creates first chimeric human

          Imageofoneofthechimerichuman-monkeyembryos.SalkInstituteforBiologicalStudiesAteamofscientistsfromthe